Search

everythinglearnresearchcommunity

for

Search:↓

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Scientists found gene mutations that affect hair loss, skin stem cells, and skin disorders, and identified drugs that may help treat blood vessel and skin conditions.

The 2004 hair research meeting presented new findings on hair cell differentiation, genetic factors in hair loss, hair pigmentation, and potential targeted therapies.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Apremilast may help treat hair loss in alopecia areata.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

People with a common type of hair loss have higher stress levels in their body, and treatments that reduce this stress could help.

Innate immunity genes in hair follicle stem cells might have new roles beyond traditional immune functions.

Alopecia areata greatly affects people's life quality, mental health, and work life.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Gut bacteria differences may help diagnose and treat Alopecia areata.

GLPLS is a rare skin condition with specific hair loss and skin symptoms.

Lung and liver macrophages protect our tissues and their dysfunction can cause various diseases.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

The 2012 criteria are better for diagnosing atypical lupus cases.

Early recognition and management of connective tissue diseases like lupus are crucial in young patients.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

Trichoscopy helps tell apart Frontal Fibrosing Alopecia and Lichen planopilaris by showing different hair and scalp features.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

Mesenchymal stem cells show promise for treating various skin conditions and may help regenerate hair.

A woman with vitiligo had a rare fungal infection around her vitiligo patch and it improved with antifungal cream.